Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
137.03
0.29 (0.21%)
At close: Oct 03, 2025, 3:59 PM
137.03
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
0.21% (1D)
| Bid | 135 |
| Market Cap | 13.59B |
| Revenue (ttm) | 2.51B |
| Net Income (ttm) | 348.3M |
| EPS (ttm) | 3.38 |
| PE Ratio (ttm) | 40.54 |
| Forward PE | 21.11 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 143.29 |
| Volume | 1,178,252 |
| Avg. Volume (20D) | 1,019,626.4 |
| Open | 137.30 |
| Previous Close | 136.74 |
| Day's Range | 135.77 - 137.79 |
| 52-Week Range | 84.23 - 154.61 |
| Beta | 0.28 |
| Ex-Dividend Date | n/a |
About NBIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNeurocrine Biosciences Inc. is scheduled to release its earnings on
Oct 29, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-6.24%
Neurocrine Biosciences shares are trading lower fo...
Unlock content with
Pro Subscription
2 months ago
+1.92%
NBIX stock has given up its prior loss. Neurocrine Biosciences shares were trading lower following Q2 reported financial results.
2 months ago · fool.com
Neurocrine (NBIX) Q2 Revenue Jumps 17%Neurocrine (NBIX) Q2 Revenue Jumps 17%
2 months ago · seekingalpha.com
Neurocrine Biosciences Positioned For Growth And New Potential BlockbustersNeurocrine Biosciences' Ingrezza still generates most of its total revenues. This is their blockbuster drug. I also believe Ingrezza is well-positioned for future growth with new label additions, and ...
2 months ago · seekingalpha.com
Neurocrine Biosciences, Inc. (NBIX) Q2 2025 Earnings Call TranscriptNeurocrine Biosciences, Inc. (NASDAQ:NBIX ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants n - Corporate Participant Eiry Wyn Roberts - Corporate Participant Strategic ...
